Predicting kinase inhibitors using bioactivity matrix derived informer sets
H. Zhang, S. S. Ericksen, C.-p. Lee, G. E. Ananiev, N. Wlodarchak, J. C. Mitchell, A. Gitter, S. J. Wright, F. M. Hoffmann, S. A. Wildman, M. A. Newton
The paper develops an informer-based ranking method to predict kinase inhibitor activity using chemogenomic data, outperforming traditional chemical diversity-based approaches in both retrospective and prospective tests.
bioRxiv · Jan 28, 2019Pharmacology & Toxicology